Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the western world. A new study published in the Journal of Hepatology shows that exercise, regardless of frequency or intensity, ...
Apr 8, 2015
0
13
As part of an effort to understand how an experimental drug for atherosclerosis causes the build-up of fat in the liver, scientists have developed a computer model that can predict how the rate at which liver stores fat in ...
Apr 1, 2015
0
5
In obese Latino and African American children, restricting dietary fructose, but not calories, may decrease liver fat and the conversion of sugar to fat in the liver, a new study finds. The results will be presented in a ...
Mar 9, 2015
0
7
Women going through menopause often struggle with weight gain that results when their estrogen levels drop, and many turn to weight-loss supplements to help them shed those extra pounds. But those supplements may cause an ...
Feb 25, 2015
0
15
Researchers at the University of Michigan have identified how a promising drug in clinical trials for the treatment of obesity and related metabolic disorders improves the metabolism of sugar by generating a new signal between ...
Jan 12, 2015
0
53
Researchers from McMaster University have identified an important hormone that is elevated in obese people and contributes to obesity and diabetes by inhibiting brown fat activity.
Dec 8, 2014
0
1
Cirrhosis and nonalcoholic fatty liver disease (NAFLD) are two serious liver conditions with limited pharmacological treatments. The December issues of AGA's journals—Clinical Gastroenterology and Hepatology and Gastroenterology—highlight ...
Nov 21, 2014
0
3
Researchers at the University of Michigan have discovered how a previously unknown hormone serves as a messenger from fat cells to the liver and are investigating the potential of developing a new treatment for metabolic ...
Nov 17, 2014
0
0
Type 2 diabetes affects an estimated 28 million Americans according to the American Diabetes Association, but medications now available only treat symptoms, not the root cause of the disease. New research from Rutgers shows ...
Oct 5, 2014
4
1
NAFLD is a progressive disease that ranges from fatty build-up (steatosis) to non-alcoholic steatohepatitis (NASH), which is inflammation around the fats. Non-alcoholic fatty liver disease is the most common liver disease ...
Oct 2, 2014
0
0
